Skip to main content
. 2021 Feb 25;13(5):952. doi: 10.3390/cancers13050952

Table 2.

Patient characteristics. Medical comorbidities and functional status at baseline.

65–69 Years n = 91 70–74 Years n = 79 75–79 Years n = 53 >80 Years n = 57 Total n = 280 p
n (%) n (%) n (%) n (%) n (%)
Medical comorbidities
Cardiovascular disease 26 (28.6) 21 (26.6) 16 (30.2) 14 (24.6) 77 (27.5) 0.907
Hypertension 37 (40.7) 28 (35.4) 22 (41.5) 26 (45.6) 113 (40.4) 0.650
Previous malignancy 5 (5.5) 4 (5.1) 6 (11.3) 1 (1.8) 16 (5.7) 0.183
Endocrine disease 7 (7.7) 5 (6.3) 5 (9.4) 3 (5.3) 20 (7.1) 0.834
Osteoarthritis 4 (4.4) 5 (6.3) 7 (13.2) 4 (7.0) 20 (7.1) 0.252
Rheumatological disease 2 (2.2) 7 (8.9) 2 (3.8) 1 (1.8) 12 (4.3) 0.122
CVA/MI/CAD 7 (7.7) 4 (5.1) 6 (11.3) 3 (5.3) 20 (7.1) 0.512
Haematological disease 0 2 (2.5) 0 0 2 (0.7) 0.167
Previous DVT 15 (16.5) 8 (10.1) 8 (15.1) 4 (7.0) 35 (12.5) 0.345
Polypharmacy (>3 meds) 31 (34.1) 27 (34.2) 23 (43.4) 30 (52.6) 111 (39.6) 0.010
Respiratory disease 6 (6.6) 15 (19.0) 6 (11.3) 1 (1.8) 28 (10.0) 0.007
Diabetes 9 (9.9) 7 (8.9) 6 (11.3) 7 (12.3) 29 (10.4) 0.850
Cognitive impairment 0 2 (2.5) 0 6 (10.5) 8 (2.9) 0.001
Depression 6 (6.6) 4 (5.1) 0 1 (1.8) 11 (3.9) 0.193
Functional baseline
Lives alone 20 (22.0) 31 (39.2) 18 (34.0) 29 (50.9) 98 (35.0) 0.000
Lives in supported accommodation 0 1 (1.3) 2 (3.8) 4 (7.0) 7 (2.5) 0.032
Use of walking aids 7 (7.7) 12 (15.2) 11 (20.8) 14 (24.6) 44 (15.7) 0.026
Reduced activities of daily living 16 (17.6) 22 (27.9) 13 (24.5) 19 (33.3) 70 (25.0) 0.226
Assistance with activities of daily living 7 (7.7) 10 (12.7) 8 (15.1) 10 (17.5) 35 (12.5) 0.441
History of delirium in last 12 months 0 0 0 3 (5.3) 3 (1.1) 0.007
Cognitive impairment 0 2 (2.5) 0 6 (10.5) 8 (2.9) 0.001
Weight loss in last 3 months 22 (24.2) 22 (27.9) 11 (20.8) 11 (19.3) 66 (23.6) 0.799
Visual impairment 3 (3.3) 1 (1.3) 2 (3.8) 9 (15.8) 15 (5.4) 0.016
Hearing impairment 1 (1.1) 0 2 (3.8) 3 (5.3) 6 (2.1) 0.242
History of falls in last 12 months 1 (1.1) 0 1 (1.9) 3 (5.3) 5 (1.8) 0.106